Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Invested Capital: 2021-2025

Historic Return on Invested Capital for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Sep 2025 value amounting to -0.26%.

  • Maravai Lifesciences Holdings' Return on Invested Capital was N/A to -0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.26%, marking a year-over-year change of. This contributed to the annual value of -0.21% for FY2024, which is N/A change from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Return on Invested Capital stood at -0.26%, which was up 35.51% from -0.40% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Return on Invested Capital's 5-year high stood at 0.50% during Q1 2022, with a 5-year trough of -0.40% in Q2 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Return on Invested Capital averaged around -0.13%, with its median value being -0.24% (2024).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first grew by 27bps in 2022, then plummeted by 33bps in 2023.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Return on Invested Capital stood at 0.48% in 2021, then fell by 11bps to 0.36% in 2022, then crashed by 33bps to 0.14% in 2023, then reached -0.23% in 2024, then reached -0.26% in 2025.
  • Its Return on Invested Capital stands at -0.26% for Q3 2025, versus -0.40% for Q2 2025 and -0.31% for Q1 2025.